Head of Investor Relations
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Susan Ringdahl is recorded as Head of Investor Relations at HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY. Susan Ringdahl has spoken on 1 earnings call across 1 company, most recently for HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY on August 6, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Head of Investor Relations
Transcript header (unverified)
Recorded roles and call appearances connecting this person to public companies.
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Head of Investor Relations
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Interim results H1 2026
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
